Ready-to-use human pancreatic organoids that recapitulate pancreatic epithelial architecture for diabetes research, pancreatic disease modeling, and drug discovery
- Overview
- Details
- Advantages
- FAQs
Overview
The human pancreas is a complex organ with both exocrine and endocrine functions, playing a critical role in digestion and glucose homeostasis. Traditional 2D cell cultures and animal models often fail to fully capture the cellular diversity and functional interactions within human pancreatic tissue, particularly for studying diseases such as diabetes and pancreatic cancer.
Pancreatic organoids are advanced 3D culture systems derived from human stem or progenitor cells that self-organize into structures resembling pancreatic tissue. These organoids primarily model pancreatic epithelial compartments, including ductal and progenitor cell populations, and provide a physiologically relevant platform for studying pancreatic biology and disease mechanisms.
What Are Pancreatic Organoids?
Organoids are 3D multicellular constructs that replicate key structural and functional aspects of native organs. Pancreatic organoids exhibit:
- Pancreatic epithelial organization with ductal-like structures
- Expression of key pancreatic lineage markers
- Capability for expansion and differentiation under defined conditions
- Suitability for modeling disease-specific phenotypes
These features make pancreatic organoids a valuable model for translational research and therapeutic development.
Fig. 1.
Pancreatic organoid generation and its applications (Balak J R, Juksar J, et al., 2019).
Our Ready-to-Use Pancreatic Organoids
Our pancreatic organoids are generated from human induced pluripotent stem cells (hiPSCs) using optimized protocols that support pancreatic lineage commitment and 3D organization. Delivered in a ready-to-use cryopreserved format, these organoids reduce experimental complexity while ensuring reproducibility and scalability.
Key Features
- Physiological relevance: Mimic pancreatic epithelial structures and cellular composition
- Functional potential: Exhibit lineage-specific gene expression and differentiation capability
- High consistency: Standardized production ensures reproducible morphology and performance
- Ready-to-use: Cryopreserved for immediate recovery and experimental application
Characterization & Validation
Our pancreatic organoids are thoroughly validated to ensure structural and functional reliability.
- Marker expression: PDX1, SOX9, CK19 (ductal/progenitor markers)
- 3D morphology: Well-defined epithelial cystic or ductal-like structures
- Functional assays: Differentiation potential toward endocrine lineages under specific conditions
- Quality control: ≥85% post-thaw viability, mycoplasma-free, low batch variability
Applications
Pancreatic organoids enable a broad range of research applications:
- Diabetes Research: Study pancreatic development and beta-cell differentiation pathways
- Disease Modeling: Model pancreatic disorders including pancreatitis and pancreatic cancer
- Drug Discovery: Screen compounds targeting pancreatic function and disease pathways
- Regenerative Medicine: Explore stem cell-based pancreatic regeneration strategies
Why Choose Our Pancreatic Organoids
- Human-relevant pancreatic model with epithelial organization
- Ready-to-use format saves weeks of differentiation time
- Reproducible and consistent across batches
- Scalable for high-throughput drug screening
- Versatile for diabetes, cancer, and regenerative studies
FAQs
Q: What cell types are represented in pancreatic organoids?
Our pancreatic organoids primarily consist of pancreatic epithelial cells, including ductal and progenitor populations. Under specific differentiation conditions, they can be directed toward endocrine lineages, enabling studies related to beta-cell development.
Q: Are these organoids suitable for diabetes research?
Yes. They provide a relevant platform for studying pancreatic development and differentiation into insulin-producing cells. While they are not fully mature islet models by default, they can be used in differentiation workflows to support diabetes-related research.
Q: How are pancreatic organoids shipped and stored?
Organoids are shipped in cryopreserved vials on dry ice or in liquid nitrogen. Upon receipt, they should be stored in liquid nitrogen until use. Detailed recovery protocols are provided to ensure optimal viability.
Q: What is the typical recovery and assay timeline?
After thawing, organoids typically recover within 24–48 hours. Most functional assays are recommended within 3–7 days post-thaw, depending on experimental design.
Q: Can pancreatic organoids be used for cancer research?
Yes. They are suitable for modeling early-stage pancreatic disease and can be adapted for tumor-related studies. We also offer customization options for disease-specific or genetically modified models.
Q: Do you provide customization or co-culture options?
Yes. We can support customized organoid development, including disease-specific models and co-culture systems with stromal or immune cells to better mimic the pancreatic microenvironment.
Accelerate pancreatic research with advanced, ready-to-use human pancreatic organoids.
Contact us to request datasheets, pricing, or customized solutions tailored to your study needs.
Online Inquiry